Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2323]

Building international collaborations and the WINTHER trial

Dr Oliver Bogler – MD Anderson Cancer Center, Houston, USA

Building international collaborations and the WINTHER trial ( Dr Oliver Bogler – MD Anderson Cancer Center, Houston, USA )

GFI is crucial for AML1-ETO induced acute myeloid leukemia

Dr Bert van der Reijden – Radboud University Nijmegen Medical Centre, Holland

GFI is crucial for AML1-ETO induced acute myeloid leukemia ( Dr Bert van der Reijden – Radboud University Nijmegen Medical Centre, Holland )

Signaling and targeting cellular pathways in leukaemia metabolism

Dr Jing Chen – Emory University School of Medicine, Atlanta, USA

Signaling and targeting cellular pathways in leukaemia metabolism ( Dr Jing Chen – Emory University School of Medicine, Atlanta, USA )

Whole genome sequence analysis for acute lymphoblastic leukaemia

Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA

Whole genome sequence analysis for acute lymphoblastic leukaemia ( Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA )

Next generation sequencing and the monoclonal structure of multiple myeloma

Dr Niccolo Bolli – University of Cambridge, UK

Next generation sequencing and the monoclonal structure of multiple myeloma ( Dr Niccolo Bolli – University of Cambridge, UK )

Mouse models and proteomics tackling acute lymphoblastic leukaemia

Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland

Mouse models and proteomics tackling acute lymphoblastic leukaemia ( Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland )

New drugs for relapsed and refractory Hodgkin's lymphoma

Prof Anas Younes - MD Anderson Cancer Center, Houston, USA

$New drugs for relapsed and refractory Hodgkin's lymphoma ( Prof Anas Younes - MD Anderson Cancer Center, Houston, USA )$

Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy

Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA

Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy ( Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA )

Novel PET tracers and their future use in assessment of response to treatment

Dr Andrei Iagaru – Stanford University, CA, USA

Novel PET tracers and their future use in assessment of response to treatment ( Dr Andrei Iagaru – Stanford University, CA, USA )

Clinical trials for rare tumour types

Dr William Tap – Memorial Sloan-Kettering Cancer Center, New York, USA

Clinical trials for rare tumour types ( Dr William Tap – Memorial Sloan-Kettering Cancer Center, New York, USA )

Regorafenib effective for GISTs that progress due to resistance to approved...

Dr George Demetri - Dana-Farber Cancer Institute, Boston, USA

Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies ( Dr George Demetri - Dana-Farber Cancer Institute, Boston, USA )

ASCO 2012: Advances in myeloma

Dr Philippe Moreau - Centre Hospitalier Universitaire de Nantes, France; Prof...

ASCO 2012: Advances in myeloma ( Dr Philippe Moreau - Centre Hospitalier Universitaire de Nantes, France; Prof Gareth Morgan - Royal Marsden Hospital, UK )

More from ecancer